Prescott Group Capital Management’s Endologix Inc ELGX Stock Holding History

Prescott Group Capital Management’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-13,030	Closed	-$943K	–	183
2017 Q1	$943K	Sell	13,030 -6,970	-35%	-$461K	0.21%	106
2016 Q4	$1.14M	Buy	+20,000	New	+$1.83M	0.24%	96

Other funds holding ELGX

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

Prescott Group Capital Management's ELGX Position: Q2 2017 in Review

Prescott Group Capital Management sold out of Endologix Inc (ELGX) in Q2 2017, closing a stake of 13,030 shares — an estimated $943K sold.

Prescott Group Capital Management first reported a position in ELGX in Q4 2016 and held it in 2 quarters. The position peaked at $1.14M in Q4 2016. 111 funds tracked by Wall St. Rank hold ELGX as of Q2 2017.

Prescott Group Capital Management reported no remaining Endologix Inc position as of Q2 2017 after selling out during the quarter.
Prescott Group Capital Management sold 13,030 Endologix Inc shares in Q2 2017, an estimated $943K.
Prescott Group Capital Management first reported a position in Endologix Inc in Q4 2016 and held it in 2 quarters.
Prescott Group Capital Management's Endologix Inc position peaked at $1.14M in Q4 2016.
111 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2017.

Based on Prescott Group Capital Management's 13F filing for Q2 2017, filed 20 Jul 2017.